【Daily Consultation by National Chief Specialists】  

Two Leading Experts Permanently Stationed, Securing Longyuan's Cancer Prevention Leadership

On January 29, Professor Wang Junjie, the tenth-term chairman of the Oncology Radiotherapy Branch of the Chinese Medical Association and president of the Lanzhou Heavy Ion Center at Gansu Wuwei Cancer Hospital, along with Professor Yu Zhilong, an authoritative expert from the Radiotherapy Department of the Affiliated Hospital of Inner Mongolia Medical University, officially joined our hospital under a permanent stationing model. Their addition injects strong momentum into the high-quality development of oncology diagnosis and treatment, profoundly reflecting the new paradigm of "localized high-end medical resources and daily services by chief experts."

As a leading figure in the field of radiation oncology in China, Professor Wang Junjie has dedicated decades to the field of tumor radiotherapy, achieving profound expertise in technological innovation and development in radiotherapy, as well as evidence-based diagnosis and treatment of complex tumors. His academic standing and clinical experience are widely regarded as benchmarks in the industry. During his tenure as the tenth-term chairman of the Oncology Radiotherapy Branch of the Chinese Medical Association, he consistently led the forefront of the discipline, spearheading the standardization and innovative development of radiotherapy technology in China. His permanent stationing and consultation at the hospital will bring patients internationally synchronized precision diagnosis and treatment strategies, as well as advanced therapeutic plans.

President Wang Junjie conducted teaching rounds in the radiotherapy ward, listening to reports from doctors across various clinical departments of our hospital. By integrating international diagnostic and treatment standards, he provided actionable solutions for the clinical staff in the radiotherapy department, charting a clear direction for the advancement of our hospital in the field of tumor diagnosis and treatment.

Professor Yu Zhilong has devoted decades to the medical profession with unwavering dedication. Formerly the Director of the Radiotherapy Department at the Affiliated Hospital of Inner Mongolia Medical University, he continues to serve on the clinical frontlines as an expert and holds a key position as a core specialist at the China Nuclear Heavy Ion Consultation Center. In the academic sphere, he was re-elected as the Chairman of the 1st and 2nd sessions of the Radiotherapy Branch of the Inner Mongolia Medical Association. At the national level, he has held significant roles such as a member of the 1st to 3rd sessions and a standing committee member of the 4th and 5th sessions of the Radiotherapy Branch of the Chinese Anti-Cancer Association, as well as a member of the 1st to 3rd sessions and a standing committee member of the 4th and 5th sessions of the Radiotherapy Branch of the Chinese Medical Doctor Association. Additionally, he serves as an editorial board member for three core journals, including the Chinese Journal of Radiation Oncology, with his academic influence extending nationwide. Renowned for his exceptional medical skills and noble ethics, he has received prestigious honors such as the nomination for the First China Bethune-Style Good Doctor Award and the First Inner Mongolia People's Good Doctor Award. Among patients, he is widely regarded as a "compassionate and caring physician."

During rounds, Professor Yu actively engaged at the bedside, working alongside the medical team of the Lanzhou Heavy Ion Center. At each patient's bedside, he meticulously conducted physical examinations, thoroughly reviewed the progress of heavy ion treatment, and held in-depth discussions with medical staff on critical issues such as treatment dose regulation and adverse reaction management. For complex cases, he emphasized that "cancer treatment requires precise strategies, integrating the patient's physical condition and tumor type and stage, while leveraging the 'pinpoint precision' advantages of heavy ion therapy alongside a comprehensive treatment approach to formulate the optimal plan." He provided on-site guidance to the team to refine diagnostic and treatment details, generously sharing cutting-edge clinical experience.

In recent years, Gansu Wuwei Cancer Hospital has achieved significant milestones in promoting the Heavy Ion Therapy Alliance and establishing 50 expert workstations. As the only hospital in the world operating two heavy ion therapy systems simultaneously, Gansu Wuwei Cancer Hospital remains steadfastly committed to the continuous development and innovation of cancer treatment technologies. The Lanzhou Heavy Ion Center is the second clinical application center for heavy ion therapy in China, independently developed with proprietary intellectual property and operated by Gansu Wuwei Cancer Hospital. This system commenced clinical operations at the Lanzhou Heavy Ion Center on November 15, 2024. To date, the center has completed photon and heavy ion treatments for over 400 patients, covering various cancer types such as lung cancer, pancreatic cancer, liver cancer, and glioblastoma.

The permanent stationing of Professor Wang Junjie and Professor Yu Zhilong at the hospital is another reflection of the Lanzhou Heavy Ion Center's commitment to its philosophy of "gathering cutting-edge global technologies to benefit cancer patients worldwide." The center not only adopts an open and inclusive approach, actively introducing internationally advanced heavy ion therapy technologies and building bridges for cross-border academic exchanges, engaging in in-depth technical dialogues and experience-sharing with top experts from countries such as Japan and Germany, but also demonstrates a pragmatic and dedicated spirit by extensively integrating domestic authoritative clinical expert resources. Through regular ward rounds, personalized consultation services, and the promotion of standardized clinical practices and homogenized treatment levels, the center continues to deepen its disciplinary development, illuminating the path of hope for cancer patients.

Professor Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology at Peking University Health Science Center

Professor Wang Junjie, President of the Lanzhou Heavy Ion Center of Gansu Provincial Wuwei Cancer Hospital and Chairman of the Oncology Radiotherapy Branch of the Chinese Medical Association

Professor Ma Lulin, Chief Physician and Professor in the Department of Urology at Peking University Third Hospital

Professor Xu Bo, Chief Physician in the Department of Radiation Oncology at Peking University Cancer Hospital

Professor Yasuo Yoshioka, renowned Japanese expert in brachytherapy and oncology from the Japanese Foundation for Cancer Research

Professor György Kovács, Honorary Retired Professor at the University of Lübeck (Germany) and Director of the Education Program at the Università Cattolica del Sacro Cuore (Italy)

In the future, the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital will continue to expand its roster of top-tier experts and refine the integrated talent cultivation system of "clinical practice, education, research, and application." With a stronger team of professionals, more precise treatment technologies, and higher-quality medical services, the center will build a solid defense line for the life and health of patients in Gansu and surrounding regions, allowing the inclusive light of "China's heavy ion technology" to illuminate the northwestern land.